rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-6-29
|
pubmed:abstractText |
To evaluate the safety and efficacy of the administration of low doses of glucocorticoids in patients with cystic fibrosis (CF) by using autologous erythrocytes loaded with dexamethasone 21-phosphate.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1079-9796
|
pubmed:author |
pubmed-author:BellaSergioS,
pubmed-author:BigiLeonardoL,
pubmed-author:CastroMassimoM,
pubmed-author:D'OrioFrancescoF,
pubmed-author:DallapiccolaBrunoB,
pubmed-author:DamonteGianlucaG,
pubmed-author:Di CarloPierluigiP,
pubmed-author:MagnaniMauroM,
pubmed-author:NovelliGiuseppeG,
pubmed-author:PanunziSimonaS,
pubmed-author:PanzaniIvoI,
pubmed-author:RossiLuigiaL,
pubmed-author:SerafiniSonjaS
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15223012-Adolescent,
pubmed-meshheading:15223012-Adult,
pubmed-meshheading:15223012-Blood Transfusion, Autologous,
pubmed-meshheading:15223012-Child,
pubmed-meshheading:15223012-Cystic Fibrosis,
pubmed-meshheading:15223012-Dexamethasone,
pubmed-meshheading:15223012-Disease Progression,
pubmed-meshheading:15223012-Erythrocyte Transfusion,
pubmed-meshheading:15223012-Erythrocytes,
pubmed-meshheading:15223012-Humans,
pubmed-meshheading:15223012-Lung Diseases,
pubmed-meshheading:15223012-Pseudomonas Infections,
pubmed-meshheading:15223012-Pseudomonas aeruginosa,
pubmed-meshheading:15223012-Recurrence,
pubmed-meshheading:15223012-Treatment Outcome
|
pubmed:articleTitle |
Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients.
|
pubmed:affiliation |
Institute of Biological Chemistry G. Fornaini, University of Urbino, 61029 Urbino, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|